Moreover, significantly higher levels were seen in patients with more advanced diseases, suggesting that the MICA shedding may contribute to prostate cancer progression Thus, consistent with Wu et al., we could speculate that high levels of circulating sMICA that we observed may be contributing to the immune tolerance observed in patients with cervical cancer. The gene discussed is MICA; the disease is Familial prostate cancer.